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Abstract 
We present a case of a rare and unusual
occurrence of a desmoid tumor at the site of a
resected  gastrointestinal  stromal  tumor  and
mimicking a recurrence, with a brief discus-
sion of the management of desmoid tumors.
Introduction
Desmoid  tumors,  also  known  as  deep  or
aggressive  fibromatoses,  are  rare  with  an
annual incidence of two to four cases per mil-
lion.
1 The term desmoid, coined by Muller in
1838, is derived from the Greek word desmos,
which means tendon-like.
2 They represent low-
grade  mesenchymal  neoplasms,  originating
from  musculo-aponeurotic  stromal  elements.
They do not metastasize but tend to exhibit a
high degree of local infiltration and invasion,
thus becoming lethal in some cases, depend-
ing on their anatomical localization.
3 Desmoid
tumor development has been associated with
genetic predisposition in patients with familial
adenomatous  polyposis  (FAP)
4 and  previous
trauma of the area.
5,6 Dysregulation of the Wnt
signaling  pathway,  which  is  involved  in  the
pathogenesis of FAP and also in the process of
wound healing, may be a critical underlying
molecular mechanism in FAP-associated cases
and possibly in sporadic ones as well.
7 In one
third of sporadic cases, chromosomal changes
such as trisomy-20 or -8 have been identified.
8
An  association  with  the  female  gender  and
pregnancy
9 suggests  a  pathogenetic  role  for
estrogenic  influence;  nevertheless,  relative
data are observational. 
We report here a rare and unusual case of
desmoid  tumor  developing  at  the  site  of  a
  gastrointestinal stromal tumor (GIST) resec-
tion.  This  created  the  impression  of  GIST
recurrence. Surgical excision of the lesion was
a difficult decision owing to the suspicion of
metastatic disease. We present a discussion on
the basis of this case for the management of
both desmoid tumors and GIST.
Case Report
A 37-year-old IT engineer with an otherwise
unremarkable medical history was admitted to
the acute assessment unit with acute upper
gastrointestinal bleeding. An ultrasound scan
of the abdomen performed as part of the work-
up for this condition revealed a large gastric
mass and liver lesions consistent with metas-
tases.  Contrast-enhanced  computed  tomog  -
raphy (CT) of the abdomen showed a 15 cm
exophytic  mass  originating  from  the  gastric
wall  (Figure  1A)  and  four  enhancing  liver
lesions of 19 mm maximum diameter (Figure
1C). Endoscopy revealed a single gastric fundal
mass  with  a  large  ulcer  that  was  biopsied.
Histological diagnosis was of a GIST, staining
positively for C-KIT and CD34 and with a high
mitotic rate. PET imaging showed a markedly
increased  uptake  in  the  gastric  mass  (SUV
15). The larger of the imaged liver lesions did
not show any significant FDG uptake while the
smaller lesions were not assessable.
Treatment with imatinib mesylate (400 mg
daily) was initiated, and the first assessment
CT scan performed three months later showed
a partial response of the gastric tumor (Figure
1B),  according  to  the  RECIST  (Response
Evaluation Criteria in Solid Tumors) criteria.
10
In addition, the liver lesions were reduced in
size uniformly. This treatment was continued
and further scans over the next five months
showed stable disease. Subsequent scans were
done as magnetic resonance imaging (MRI) to
assess the extent of the hepatic lesions, from
which  it  was  concluded  that  they  were  not
metastatic  in  nature.  In  light  of  a  good
response to treatment the patient underwent a
total  abdominal  gastrectomy.  The  procedure
achieved excision of the tumor together with
an intraoperatively detected omental second-
ary lesion (Figures 1C). Pathological findings
reported  positive  margins  (microscopic-R1
resection)  at  the  splenic  and  pancreatic
aspects. Imatinib was continued postoperative-
ly.  Plans  for  surgical  removal  of  the  liver
lesions were abandoned when the MRI scan of
the  liver  revealed  multiple  nonspecific  tiny
lesions  widespread  throughout  the  liver
parenchyma.
The  patient  remained  asymptomatic  and
well  on  imatinib  treatment  for  another  11
months,  when  a  repeat  MRI  scan  of  the
abdomen revealed a new mesenteric mass 3
cm in diameter (Figure 1D), while the appear-
ance of the liver lesions remained unchanged.
A multidisciplinary team meeting decision was
made  to  resect  the  lesion  surgically.  The
excised  lesion  represented  a  firm  nodular
mass  with  a  thin  connective  tissue  capsule,
measuring  6.0¥4.0¥4.5  cm  (Figure  2).  A
mesenteric  and  an  anterior  abdominal  wall
nodule were also removed. Microscopically the
larger mass appeared as a circumcised unen-
capsulated tumor of varying cellularity. Toward
the periphery it was composed of spindle cells
with elongated nuclei and a small amount of
pale eosinophilic cytoplasm arranged between
broad  sweeping  fascicles  (Figure  3A).  No
nuclear atypia was noted. Toward the center of
the lesion there was pronounced keloidal colla-
gen deposition (Figure 3B). The tumor showed
weak staining for desmin and was negative for
CD34 and C-KIT. The pattern was typical of an
intra-abdominal desmoid tumor. The other two
nodules turned out to be a mesenteric lymph
node with sinus histiocytosis and a pseudo-
cyst  with  no  evidence  of  malignancy.  The
patient continued on imatinib (400 mg OD)
treatment  and  follow-up  MRI  scans  did  not
show  any  recurrence  of  the  desmoid  tumor
over the next eight months. 
Discussion
Desmoid tumors usually manifest as slow-
growing,  deep-seated,  painless  or  slightly
painful masses and can develop at virtually any
anatomical site.
11 Typically three localizations
are described: trunk/extremity, abdominal wall,
and intra-abdominal region. Usually FAP-asso-
ciated cases occur in the abdomen, while non-
FAP-associated cases present in the shoulder
or hip regions and in the extremities.
5 They
can be multifocal on an extremity, but different
anatomical regions rarely are affected in the
same  patient.  Inside  the  abdomen  they  can
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cause changes in bowel habits, pain, obstruc-
tion, ischemia, rectal bleeding, or a dysfunc-
tional anastomosis, and are a significant cause
of mortality for FAP patients. Non-intra-abdom-
inal desmoids have a better prognosis.
7,12
Complete  surgical  resection  remains  the
cornerstone  of  management  of  desmoid
tumors, while unresectable or residual disease
can  be  treated  with  radical  radiotherapy.
11
Depending on tumor size, type of treatment,
and  negative  margins  post-resection,  recur-
rences  occur  in  up  to  45%  of  treated  adult
cases, usually within three years from diagno-
sis.
13 Systemic treatments with NSAIDs, anti  -
estrogens or androgens, chemotherapy (dox-
orubicin-based,  methotrexate,  vinblastine,
vinorelbine),  and  lately  imatinib  have  been
used  for  unresectable  or  relapsed  desmoids,
often resulting in long-lasting responses.
14 In
selected  asymptomatic  patients,  a  period  of
watchful waiting is recommended.
15
Prior trauma is identified in 30% of patients
who develop desmoid tumors, and is typically
abdominal surgery for FAP.
4 In addition, spor  -
adic cases of intra-abdominal desmoid tumors
have been observed in sites of previous abdom-
inal surgery.
12,16,17 Our literature search yielded
one previous report of a desmoid tumor arising
in the site of a previously excised GIST.
18 GISTs
and desmoid tumors share a common stromal
origin but are diverse histologically, genetical-
ly, and biologically. Nevertheless, surgical trau-
ma at the GIST excision site may predispose to
the  development  of  the  desmoid  tumor.  An
accurate diagnosis is possible only after surgi-
cal removal and pathological exam  ination, as
there are no typical imaging findings to sug-
gest a desmoid tumor. Excluding recurrence of
the GIST was crucial for the further manage-
ment of our patient; he remained on imatinib
for the metastatic GIST; therefore he contin-
ued  to  benefit  from  first-line  treatment  and
remains progression-free after eight months. 
References
1. Reitamo JJ, Häyry P, Nykyri E, Saxén E.
The  desmoid  tumor.  Incidence,  sex,  age
and anatomical distribution in the Finnish
population. Am J Clin Pathol 1982;77:665-
73. 
2. Müller J. Veber den Feinern Bau und die
Formen der Krankhaftlichen Geschwulste.
Berlin: G Reimer, p 80, 1838.
3. Schlemmer M. Desmoid tumors and deep
fibromatoses.  Hematol  Oncol  Clin  North
Am 2005;19:565-71.
4. Soravia C, Berk T, McLeod RS, Cohen Z.
Desmoid disease in patients with familial
adenomatous polyposis. Dis Colon Rectum
2000;43:363-9. 
5. De  Cian  F,  Delay  E,  Rudigoz  RC,  et  al.
Desmoid tumor arising in a Cesarean sec-
tion  scar  during  pregnancy:  monitoring
and management. Gynecol Oncol 1999;75:
145-8. 
6. Penna C, Tiret E, Parc R, et al. Operation
and abdominal desmoid tumors in familial
adenomatous  polyposis.  Surg  Gynecol
Obstet 1993;177:263-8. 
7. Kotiligam D, Lazar AJ, Pollock RE, Lev D.
Desmoid tumor: a disease opportune for
molecular  insights.  Histol  Histopathol
2008;23:117-26. 
8. Dei Tos AP, Dal Cin P. The role of cyto  -
Case Report
Figure 1. A contrast-enhanced computed tomography scan of the abdomen showing: a
15-cm exophytic mass originating from the gastric wall (arrow) (A); and four enhancing
liver lesions of maximal diameter of 19 mm (C). A three-month follow-up abdominal CT
scan (B) demonstrated a partial response to treatment of the gastric tumor (arrow). A
repeat MRI scan of the abdomen after 11 months revealed a secondary mesenteric omen-
tal mass, 3 cm in diameter (D).
Figure 2. Macroscopic view of the second-
ary mesenteric lesion, showing it as a firm
nodular mass with a thin connective tissue
capsule, measuring 6.0¥4.0¥4.5 cm.
Figure 3. A histological section of the larg-
er mass illustrating: (A) toward the periph-
ery of the tumor, spindle cells with elongat-
ed  nuclei  and  a  small  amount  of  pale
eosinophilic  cytoplasm,  and  (B)  pro-
nounced  keloidal  collagen  deposition
toward the center of the lesion. No nuclear
atypia was noted. (Hematoxylin and eosin
stain; magnification 100X).
A
B[Rare Tumors 2010; 2:e33] [page 93]
genetics in the classification of soft tissue
tumours. Virchows Arch 1997;431:83-94. 
9. Gansar GF, Markowitz IP, Cerise EJ. Thirty
years of experience with desmoid tumors at
Charity Hospital. Am Surg 1987;53:318-9. 
10. Therasse P, Arbuck SG, Eisenhauer EA, et
al.  New  guidelines  to  evaluate  the
response to treatment in solid tumors. J
Natl Cancer Inst 2000;92:205-16. 
11. Ballo  MT,  Zagars  GZ,  Pollack  A,  et  al.
Desmoid  Tumor:  Prognostic  Factors  and
Outcome  After  Surgery,  Radiation
Therapy,  or  Combined  Surgery  and
Radiation Therapy. J Clin Oncol 1999;17:
158-67. 
12. Enzinger  FM,  Weiss  SW.  Soft  Tissue
Tumors. 3rd ed. St Louis: Mosby-Yearbook
Inc., p 201, 1995.
13. Nuyttens JJ, Rust PF, Thomas CR Jr, et al.
Surgery  versus  radiation  therapy  for
patients  with  aggressive  fibromatosis  or
desmoid tumors: a comparative review of
22 articles. Cancer 2000;88:1517-23. 
14. Patel SR, Benjamin RS. Desmoid Tumors
Respond  to  Chemotherapy:  Defying  the
Dogma in Oncology. J Clin Oncol 2006;24:
11-2. 
15. De  Bree  E,  Keus  R,  Melissas  J,  et  al.
Desmoid tumours: Need for an individual-
ized approach. Expert Rev Anticancer Ther
2009;9:525-35.
16. Kersting  S,  Herbst  H,  Senninger  N,
Mittelkötter U. Intra-abdominal fibromato-
sis after ap  pendectomy as cause for ileus.
Zentralbl Chir 2004;129:317-20. 
17. Moudouni SM, Tazi Mokha K, Nouri M, et
al. Desmoid tumor of the mesentery sec-
ondary to colectomy. An exceptional cause
of ureteric obstruction. Ann Urol 1999;33:
424-7. 
18. Vendrell J-F, Mazars R, Funakoshi N, et al.
Desmoid tumor subsequent to resection of
a  gastrointestinal  stromal  tumor.  Eur  J
Radiol 2008;65:9-11. 
Case Report